{"count": 2, "results": [{"_id": "39557773", "pmid": 39557773, "title": "Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.", "journal": "High Blood Press Cardiovasc Prev", "authors": ["Habboush S", "Kagita NV", "Gadelmawla AF", "Elmoursi A", "Merza N", "Abdo AA", "Zahran AHM", "Eldeib M", "Almarghany AA", "Abdelfadil MM", "Abdelkarim MA", "Shawky I", "Mohammed OM", "Alharran A", "Ali MM", "Elbardisy S"], "date": "2024-11-19T00:00:00Z", "doi": "10.1007/s40292-024-00689-3", "meta_date_publication": "2024 Nov 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50274.227, "text_hl": "AIM: This study investigated the comparative efficacy and safety of a three-drug regimen (TAR) containing @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@, @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ against two-drug combinations (@<m>CHEMICAL_telmisartan_amlodipine_combination</m> @CHEMICAL_MESH:C548840 @@@TA@@@ and TR) for managing @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@. ", "citations": {"NLM": "Habboush S, Kagita NV, Gadelmawla AF, Elmoursi A, Merza N, Abdo AA, Zahran AHM, Eldeib M, Almarghany AA, Abdelfadil MM, Abdelkarim MA, Shawky I, Mohammed OM, Alharran A, Ali MM, Elbardisy S. Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis. High Blood Press Cardiovasc Prev. 2024 Nov 19;():. PMID: 39557773", "BibTeX": "@article{39557773, title={Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.}, author={Habboush S and Kagita NV and Gadelmawla AF and Elmoursi A and Merza N and Abdo AA and Zahran AHM and Eldeib M and Almarghany AA and Abdelfadil MM and Abdelkarim MA and Shawky I and Mohammed OM and Alharran A and Ali MM and Elbardisy S}, journal={High Blood Press Cardiovasc Prev}}"}}, {"_id": "37033509", "pmid": 37033509, "pmcid": "PMC10078117", "title": "Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial", "journal": "Cureus", "authors": ["Dash A", "Meher BR", "Padhy BM", "Mohanty RR", "Tripathy A"], "date": "2023-03-07T00:00:00Z", "doi": "10.7759/cureus.35865", "meta_date_publication": "2023 Mar", "meta_volume": "15", "meta_issue": "3", "meta_pages": "e35865", "score": 50249.008, "text_hl": "...@<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@Hypertension@@@ (@<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@HTN@@@) is one of the most common conditions encountered in daily practice in hospitals. ", "citations": {"NLM": "Dash A, Meher BR, Padhy BM, Mohanty RR, Tripathy A. Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial Cureus. 2023 Mar;15(3):e35865. PMID: 37033509", "BibTeX": "@article{37033509, title={Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial}, author={Dash A and Meher BR and Padhy BM and Mohanty RR and Tripathy A}, journal={Cureus}, volume={15}, number={3}, pages={e35865}}"}}]}